186 related articles for article (PubMed ID: 16495244)
1. Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus.
Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Taparkou A; Kanakoudi-Tsakalidou F; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2006 Mar; 50(3):868-73. PubMed ID: 16495244
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus.
Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Panteliadis C; Walsh TJ; Roilides E
J Antimicrob Chemother; 2008 Apr; 61(4):810-7. PubMed ID: 18272514
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B.
Simitsopoulou M; Roilides E; Dotis J; Dalakiouridou M; Dudkova F; Andreadou E; Walsh TJ
Antimicrob Agents Chemother; 2005 Apr; 49(4):1397-403. PubMed ID: 15793118
[TBL] [Abstract][Full Text] [Related]
4. Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus.
Simitsopoulou M; Roilides E; Georgiadou E; Paliogianni F; Walsh TJ
Med Mycol; 2011 Feb; 49(2):176-85. PubMed ID: 20807031
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
Krishnan S; Manavathu EK; Chandrasekar PH
J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
[TBL] [Abstract][Full Text] [Related]
6. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus.
Roilides E; Dimitriadou A; Kadiltsoglou I; Sein T; Karpouzas J; Pizzo PA; Walsh TJ
J Immunol; 1997 Jan; 158(1):322-9. PubMed ID: 8977206
[TBL] [Abstract][Full Text] [Related]
7. Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.
Groll AH; Lyman CA; Petraitis V; Petraitiene R; Armstrong D; Mickiene D; Alfaro RM; Schaufele RL; Sein T; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2006 Oct; 50(10):3418-23. PubMed ID: 17005824
[TBL] [Abstract][Full Text] [Related]
8. In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods.
Bugli F; Posteraro B; Papi M; Torelli R; Maiorana A; Paroni Sterbini F; Posteraro P; Sanguinetti M; De Spirito M
Antimicrob Agents Chemother; 2013 Mar; 57(3):1275-82. PubMed ID: 23263007
[TBL] [Abstract][Full Text] [Related]
9. Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus.
Roilides E; Lyman CA; Filioti J; Akpogheneta O; Sein T; Lamaignere CG; Petraitiene R; Walsh TJ
Antimicrob Agents Chemother; 2002 Jun; 46(6):1974-6. PubMed ID: 12019118
[TBL] [Abstract][Full Text] [Related]
10. Interactions of liposome carriers with infectious fungal hyphae reveals the role of β-glucans.
Chavan NL; Young JK; Drezek RA; Lewis R; Bikram M
Mol Pharm; 2012 Sep; 9(9):2489-96. PubMed ID: 22770505
[TBL] [Abstract][Full Text] [Related]
11. Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
Simitsopoulou M; Roilides E; Maloukou A; Gil-Lamaignere C; Walsh TJ
Mycoses; 2008 Mar; 51(2):147-54. PubMed ID: 18254752
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus.
Al-Nakeeb Z; Petraitis V; Goodwin J; Petraitiene R; Walsh TJ; Hope WW
Antimicrob Agents Chemother; 2015 May; 59(5):2735-45. PubMed ID: 25712363
[TBL] [Abstract][Full Text] [Related]
14. Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
Chryssanthou E; Sjölin J
J Antimicrob Chemother; 2004 Nov; 54(5):940-3. PubMed ID: 15471994
[TBL] [Abstract][Full Text] [Related]
15. Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
Chryssanthou E; Loebig A; Sjölin J
J Antimicrob Chemother; 2008 Jun; 61(6):1309-11. PubMed ID: 18367461
[TBL] [Abstract][Full Text] [Related]
16. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae.
Lass-Flörl C; Nagl M; Gunsilius E; Speth C; Ulmer H; Würzner R
Mycoses; 2002 Jun; 45(5-6):166-9. PubMed ID: 12100533
[TBL] [Abstract][Full Text] [Related]
18. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro.
Heller I; Leitner S; Dierich MP; Lass-Flörl C
Int J Antimicrob Agents; 2004 Oct; 24(4):401-4. PubMed ID: 15380269
[TBL] [Abstract][Full Text] [Related]
19. What is the current and future status of conventional amphotericin B?
Kleinberg M
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
